A test designed to identify biomarkers associated with autism in infants and young children is now available to the public in most states. LinusBio, a New Jersey-based startup, on Thursday launched ...
The SA74 LB Test offers several advantages over traditional tissue biopsy methods, the company claims. (Image Credits: Pixabay) Strand Life Sciences, a subsidiary of Reliance Industries Limited, on ...
The test utilises unique molecular identifiers (UMIs) to ensure high-confidence detection of genetic variants, making it a reliable tool for identifying potential biomarkers and guiding treatment ...
A New York startup has developed a new test that could potentially help with the diagnosis of autism in children at an earlier age than is now possible. Getty Images Lock it in. Scientists are buzzing ...
Strand Life Sciences, a subsidiary of Reliance Industries Limited recently announced the launch of its somatic advantage 74 liquid biopsy (SA74 LB) test. This test detects circulating tumour DNA in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results